Ownership history in Simplify Asset Management Inc. · 7 quarters on record
This page tracks every 13F SEC filing in which Simplify Asset Management Inc. reported a position in United Therapeutics Corp (UTHR). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | ADDED | 23,839 | +3,919 | +19.7% | 0.19% | $11.6M | $487.25 |
| 2025 Q3 | ADDED | 19,920 | +18,612 | +1422.9% | 0.15% | $8.4M | $419.21 |
| 2022 Q4 | REDUCED | 1,308 | -6,606 | -83.5% | 0.06% | $364K | $278.09 |
| 2022 Q3 | ADDED | 7,914 | +2,475 | +45.5% | 0.18% | $1.7M | $209.38 |
| 2022 Q2 | ADDED | 5,439 | +1,089 | +25.0% | 0.05% | $1.3M | $235.64 |
| 2022 Q1 | ADDED | 4,350 | +2,178 | +100.3% | 0.02% | $780K | $179.41 |
| 2021 Q4 | INITIATED | 2,172 | — | — | 0.02% | $469K | $216.08 |
As of 2025 Q4 — sorted by position size